NCCN Imaging Appropriate Use Criteria (20 types of cancer + ovarian cancer)

NCCN Imaging Appropriate Use Criteria

NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™)

 NCCN Imaging AUC currently are available for 20 cancer types; the new NCCN Imaging AUC are available for:

• Esophageal and Esophagogastric Junction Cancers
• Gastric Cancer
• Malignant Pleural Mesothelioma
• Melanoma
• Ovarian Cancer
• Penile Cancer
• Small Cell Lung Cancer
• Thymomas and Thymic Carcinomas

About NCCN Imaging AUC™
NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) include information designed to support clinical decision-making around the use of imaging in patients with cancer and are based directly on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®). NCCN Imaging AUC™ are available free of charge to registered users of NCCN.org
NCCN Imaging AUC™ include recommendations pertaining to cancer screening, diagnosis, staging, treatment response assessment, follow-up, and surveillance. Additional information includes the indication, imaging modality, and frequency of use, as well as clinical notes related to the specific recommendation. NCCN Imaging AUC™ also document information on disease stage and histology. All imaging procedures recommended in the NCCN Guidelines^®, including radiographs, computed tomography (CT) scans, magnetic resonance imaging (MRI), functional nuclear medicine imaging (PET, SPECT) and ultrasound, are included within NCCN Imaging AUC™.
NCCN Imaging AUC™ are accessible through an easy to use web-based user interface. The NCCN Imaging AUC™ include a full complement of imaging AUC in oncology care. NCCN, a CMS-approved Provider Led Entity (PLE), is committed to assuring that the most up-to-date recommendations are available and reviews and updates NCCN Imaging AUC™ on a continual basis to ensure that the recommendations take into account the most current evidence.